Plain-English translation of NCT04012658 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term observational study that follows people with Wilson's Disease, people who carry the Wilson's Disease gene without symptoms, their relatives, and healthy controls. Researchers will collect medical information, genetic data, and blood samples from up to 2,000 participants across multiple medical centers to better understand how Wilson's Disease develops and progresses over time.
Wilson's Disease is a rare genetic disorder where copper builds up in the body and damages organs, but doctors still don't fully understand how it affects different patients or how to best predict and manage it. This study aims to gather detailed information about the disease's natural progression and identify biological markers that could help doctors personalize treatment and catch the disease earlier.
You likely qualify if…
You likely don't qualify if…
Depending on your group, you will attend visits at one of the participating medical centers where researchers will collect your medical history, perform physical exams, and take blood or tissue samples for genetic and biomarker testing. You may also be asked to share existing medical records. The study will continue to monitor and collect information from you over time to track how Wilson's Disease develops and progresses.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
China
Sponsor
Wan-Jin Chen
Enrollment target
~2,000 participants
Started
July 2019
Primary completion
December 2039
Last updated on clinicaltrials.gov in September 2019.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jin He, MD
Wan-Jin Chen
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.